Oramed Pharmaceuticals, Inc Stock, NASDAQ:ORMP
1185 Avenue of the Americas, 3rd Floor, New York, New York 10019
United States of America
Number of Employees: 13
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.